We recommend that you upgrade to the latest version of your browser.
The image shows a pathology section on a slide, digital pathology sections with stained features, histotyping and further code snippets on a screen

Institute for Cancer Genetics and Informatics

For more than two decades, the Institute for Cancer Genetics and Informatics has been driving innovation in cancer diagnostics and prognostication. At the heart of our research is artificial intelligence, powering advanced image analysis of cancer cells and tissues to uncover tumour heterogeneity and disease progression. We create and refine digital pathology tools that make visualisation and interpretation of complex cancer images more precise and accessible. Through strong national and international collaborations, we turn cutting-edge research into real progress for cancer care.

Our vision is to strengthen Oslo University Hospital by providing knowledge and expertise to empower clinical decision-making and improve patient care. We develop innovative methods for cancer treatment, with a strong focus on digital image analysis and prognostication, paving the way for more precise and personalized diagnostics and therapy.

External links to the institute's websites and project pages

The institute is led by Tarjei Sveinsgjerd Hveem.

Håvard E. G. Danielsen (1957–2023) founded the institute in 2004. Until his death in 2023, Danielsen was a pioneer and a world-leading expert in digital pathology and artificial intelligence. In 2022, he was awarded the King Olav V Cancer Research Prize from the Cancer Society and the "Excellent Researcher Award" from Oslo University Hospital.

Section for Interphase Genetics

The section is led by Hanne Askautrud and is heavily involved in the institute's research activities. Marna Lill Kjæreng leads the unit for laboratories.

Section for Applied Informatics

John Arne Nesheim leads the section that works on software development, project management, operation of data systems, digital image analysis, quality assurance, web development, and research dissemination. The section has extensive expertise in developing systems for deep learning via neural networks, also referred to as artificial intelligence.

The Section for cancer cytogenetics was up until January 2026 a part of the institute  but is now a part of the department of Pathology

User council

Purpose of the User Council

Our User Council brings the perspectives of people affected by cancer into all aspects of the Institute’s research activities. Since 2019, the User Council offers strategic and practical guidance to ensure the Institute's research priorities aligns with users’ needs and experiences.

Value of user involvement

We are confident that meaningful user involvement strengthens our research quality, relevance, and impact, and supports responsible and ethically robust research practice.

Organisations Represented in our User Council

The User Council at ICGI is composed of representatives from the following national cancer patient organisations in Norway:

  • NORILCO (Gastrointestinal cancer) 
  • PROFO (Prostate cancer) 
  • The Norwegian Association for Gynaecological Cancer 
  • The Norwegian Society for Lung Cancer 
  • Norwegian association for melanoma (“Melanomforeningen”)
  • Norwegian association for sarcoma (Sarkomer)
  • Blodkreftforeningen (Hematopoietic cancer) 

Contact

Phone

Administrasjon

22 78 23 21
  • Monday - Friday 8:30 AM - 3:30 PM
  • Saturday - Sunday CLOSED

Seksjon for kreftcytogenetikk (prøvelevering)

91 33 05 79
  • Monday - Friday 8:30 AM - 4:00 PM
  • Saturday 9:30 AM - 2:00 PM
  • Sunday CLOSED

24.12, 31.12 og onsdag før skjærtorsdag: 08:00-12:00 Helligdager: stengt

Seksjon for interfasegenetikk

22 78 23 35
  • Monday - Friday 9:00 AM - 3:00 PM
  • Saturday - Sunday CLOSED

Postal address

Oslo universitetssykehus HF, Radiumhospitalet

Institutt for kreftgenetikk og informatikk,

Postboks 4953 Nydalen

0424 Oslo

E-mail

hramstad@ous-hf.no
cytogenetikk@radiumhospitalet.no

Directions

Contact point

The institute is located at Ullernchausséen 64, next to the Radium Hospital. Entrance 2A, on the 5th to 7th floor.
A large building with a person riding a bicycle

Oslo Cancer Cluster Innovasjonspark ved Radiumhospitalet

Ullernchausseen 64/66

0379 Oslo

Finn frem